Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs Silo Pharma, Inc. (SILO)

Biorestorative Therapies, Inc. and Silo Pharma, Inc. are both Biotechnology companies. Biorestorative Therapies, Inc. and Silo Pharma, Inc. are of similar size ($2.0M and $1.9M). Silo Pharma, Inc. grew revenue faster over the last twelve months: 0.00% against −8.47%. Silo Pharma, Inc. has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Silo Pharma, Inc. leads on 12 and Biorestorative Therapies, Inc. on 5.

Valuation

Metric BRTX SILO Biotechnology median
P/E n/m n/m 8.50
P/S 3.76 18.00 9.71
P/B 0.45 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 0.90 0.64
EV/Sales (5.74) (54.56) 9.21
Earnings yield (1,407.89%) (369.34%) (33.15%)
Free cash flow yield (972.97%) (302.55%) (25.50%)

Profitability

Metric BRTX SILO Biotechnology median
Gross margin 92.09% 11.81% 65.16%
Operating margin (3,974.66%) 0.00% 0.00%
Net margin (3,089.30%) 0.00% 0.00%
Free cash flow margin (3,302.04%) 0.00% 0.00%
Return on equity (241.50%) (91.23%) (56.36%)
Return on assets (147.75%) (70.96%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BRTX SILO Biotechnology median
Revenue growth (TTM) (8.47%) 0.00% 6.02%
EPS growth (last fiscal year) (36.21%) 57.98% 30.26%
Revenue growth, 5-year CAGR 36.11% 12.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRTX SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.35 5.36 4.72
Net debt to EBITDA 0.19 1.61 0.96

Dividend

Metric BRTX SILO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BRTX SILO Biotechnology median
Market cap 2.01m 1.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack